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Essentials
• Dimeric high-affinity collagen receptor glycoprotein VI
(GPVI) is present on resting platelets.
• Spatio-temporal organization of platelet GPVI-dimers
was evaluated using advanced microscopy.
• Upon platelet adhesion to collagenous substrates,
GPVI-dimers coalesce to form clusters.
• Clustering of GPVI-dimers may increase avidity and
facilitate platelet activation
Summary. Background: Platelet glycoprotein VI (GPVI)
binding to subendothelial collagen exposed upon blood
vessel injury initiates thrombus formation. Dimeric GPVI
has high affinity for collagen, and occurs constitutively
on resting platelets. Objective: To identify higher-order
oligomerization (clustering) of pre-existing GPVI dimers
upon interaction with collagen as a mechanism to initiate
GPVI-mediated signaling. Methods: GPVI was located by
use of fluorophore-conjugated GPVI dimer-specific Fab
(antigen-binding fragment). The tested substrates include
Horm collagen I fibers, soluble collagen III, GPVI-speci-
fic collagen peptides, and fibrinogen. GPVI dimer clusters
on the platelet surface interacting with these substrates
were visualized with complementary imaging techniques:
total internal reflection fluorescence microscopy to
monitor real-time interactions, and direct stochastic opti-
cal reconstruction microscopy (dSTORM), providing rela-
tive quantification of GPVI cluster size and density.
Confocal microscopy was used to locate GPVI dimer
clusters, glycoprotein Ib, integrin a2b1, and phosphotyro-
sine. Results: Upon platelet adhesion to all collagenous
substrates, GPVI dimers coalesced to form clusters; nota-
bly clusters formed along the fibers of Horm collagen.
dSTORM revealed that GPVI density within clusters
depended on the substrate, collagen III being the most
effective. Clusters on fibrinogen-adhered platelets were
much smaller and more numerous; whether these are pre-
existing oligomers of GPVI dimers or fibrinogen-induced
is not clear. Some GPVI dimer clusters colocalized with
areas of phosphotyrosine, indicative of signaling activity.
Integrin a2b1 was localized to collagen fibers close to
GPVI dimer clusters. GPVI clustering depends on a
dynamic actin cytoskeleton. Conclusions: Platelet adhe-
sion to collagen induces GPVI dimer clustering. GPVI clus-
tering increases both avidity for collagen and the proximity
of GPVI-associated signaling molecules, which may be cru-
cial for the initiation and persistence of signaling.
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Introduction
Upon blood vessel injury, circulating platelets interact
with exposed subendothelial collagen through the collagen
receptor glycoprotein VI (GPVI). This 65-kDa immune
receptor signals through its associated Fc-receptor
c-chain, which contains an immunoreceptor tyrosine-
based activation motif (ITAM) in its intracellular domain.
Binding of GPVI to collagen induces phosphorylation of
the ITAM residues, which can then bind to Syk, which
itself becomes phosphorylated and activated. This process
initiates signalosome assembly [1], leading to a series of
downstream signals, resulting in platelet activation, finally
culminating in thrombus formation.
GPVI contains two extracellular Ig-like domains: D1,
containing the collagen-binding site [2,3]; and D2, connected
via an O-glycosylated stem to its transmembrane domain
and short cytoplasmic tail [4]. GPVI binds to tandem
glycine–proline–hydroxyproline (GPO) sequences in colla-
gen [5,6]. Surface plasmon resonance showed that dimerized
recombinant GPVI (D1D2-Fc)2 bound collagen fibers with
high affinity, but binding of its monomeric form (D1D2)
was too low to be measured [7]. Monomeric and dimeric
recombinant D1D2 showed similar affinities for collagen-
related peptide (CRP), a triple-helical peptide containing 10
contiguous GPO triplets, suggesting that GPVI dimers may
have a specific conformation that recognizes the higher-
order structure of fibrous collagen, beyond simply the GPO
sequences. The crystal structure of a D1D2 dimeric assem-
bly [8] allowed docking simulations [3,5,8], which suggested
that D1 contained grooves large enough to accommodate
the triple-helical CRP. In 2009, Jung et al. provided direct
evidence for the presence of dimers on the resting platelet
surface with GPVI dimer-specific, inhibitory m-Fab-F [9].
Later, they reported a non-inhibitory Fab, 204-11, which
recognized GPVI dimers [10], and used it to show that GPVI
dimers were constitutively present on resting platelets. These
observations suggested that the first interaction in collagen-
induced activation of platelets is collagen binding to GPVI
dimers. Several groups, however, reported that platelet acti-
vation induced the formation of GPVI dimers. Arthur et al.
[11] provided biochemical evidence for disulfide-linked
dimers in activated platelets. Loyau et al., employing GPVI
dimer-specific mAb 9E18, reported that GPVI dimerization
was induced by soluble agonists or von Willebrand factor
(VWF), with almost no dimers being detected on resting pla-
telets [12], leading them to propose dimer formation as a
means to control collagen-induced platelet activation.
Dimerization is an accepted mechanism for cell activation
through receptor tyrosine kinases [13], whereby ligand bind-
ing to the receptor extracellular domains induces dimeriza-
tion, causing a conformational change that brings together
the kinase domains in the cytoplasmic tails, facilitating
autophosphorylation, and thereby initiating intracellular
signals. The Src-family kinase Lyn associates with the cyto-
plasmic tail of GPVI [14], which lacks intrinsic kinase
activity, so that FcRc attached to one GPVI monomer
might be phosphorylated by Lyn associated with a second
monomer, brought into proximity by dimerization.
An alternative activation mechanism would be higher-
order receptor clustering [15], which does not preclude
the presence of constitutive GPVI dimers in non-activated
platelets. Clustering has been demonstrated for many
classes of receptor, including G-protein-coupled receptors
[16], adhesion receptors such as platelet integrin aIIbb3
[17], platelet C-type lectin-like receptor 2 [18], and, nota-
bly, discoidin domain receptor 1, a constitutively dimeric
tyrosine kinase receptor for collagen [19].
As GPVI dimers are present on resting platelets, we
hypothesize that a further level of control is required. We
hypothesize that clustering of GPVI dimers is a plausible
mechanism to modulate platelet activation once the high-
affinity, but low-copy-number, GPVI dimers engage the
limited number of binding sites on collagen [2,20]. The
formation of GPVI clusters could result in increased avid-
ity and may bring associated signaling molecules together
to facilitate platelet activation. We used complementary
imaging techniques to test this hypothesis: total internal
reflection fluorescence microscopy (TIRFM), to visualize
in real time GPVI dimer distribution at the interface
between the platelet membrane and immobilized collage-
nous substrates; direct stochastic optical reconstruction
microscopy (dSTORM) for relative quantification of
GPVI cluster size and density; and confocal microscopy
to compare the localization of GPVI dimers and two
other receptors involved in the platelet–collagen interac-
tion, i.e. glycoprotein Ib (GPIb) and a2b1, and whether
signaling was associated with the clustered GPVI dimers.
Materials and methods
Non-inhibitory, recombinant dimer-specific 204-11 Fab [10]
was derived from clone 204-11 [21] by Kaketsuken (Kuma-
moto, Japan). Antibodies were fluorescently labeled by use
of a Microscale Protein Labelling kit (Molecular Probes,
Eugene, OR, USA); degree of fluorescent labeling = 2–5 dye
molecules per protein molecule. The antibodies used were:
4G10 (anti-phosphotyrosine; Millipore Merck, Billerica, MA,
USA); anti-human CD42b/GPIb, clone 486805 (R&D Sys-
tems, Abingdon, UK); 16B4 (mouse anti-human CD49b/inte-
grin a2 chain; Bio-Rad, Hercules, CA, USA); Alexa Fluor
647-conjugated AffiniPure F(ab0)2 fragment goat anti-mouse
IgG, Fcc-specific (Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA, USA); Gi9 (anti-integrin a2; Abcam,
Cambridge, UK); and Alexa Fluor 647-conjugated anti-
human CD62P (Bio-Rad). Other materials, of reagent grade
or better, were obtained from commercial sources.
Platelet preparation
Washed platelets were prepared from acid–citrate–dex-
trose-anticoagulated blood from healthy volunteers [22],
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and resuspended at 3–5 9 107 platelets mL1 in HEPES–
Tyrodes buffer (HT) (134 mM NaCl, 0.34 mM Na2HPO4,
2.9 mM KCl, 12 mM NaHCO3, 20 mM HEPES, 5 mM glu-
cose, pH 7.3).
Preparation of collagenous substrate-coated glass dishes for
imaging
Thirty-five-millimeter glass (0.7 mm)-bottomed MatTek
dishes (MatTek, Ashland, MA, USA) were coated with
10 lg mL1 cross-linked CRP (CRP-XL), III-30, or colla-
gen III (Col III), in phosphate-buffered saline (PBS)
(0.01 M phosphate buffer, 0.0027 M KCl, 0.137 M NaCl,
pH 7.4) and Horm collagen (Horm), in manufacturer-sup-
plied diluent, overnight at 4 °C. The dishes were washed
with PBS, blocked with 1% bovine serum albumin/PBS
(heat-denatured, filtered) for 1 h, and then washed with
PBS to make them ready for platelet spreading.
TIRFM
Adhesion of Alexa Fluor 488–204-11 Fab-labeled washed
platelets (3 9 107 platelets mL1 in HT containing 2 mM
MgCl2) to immobilized collagenous substrate was imaged
with TIRFM (Nikon TIRF system mounted on a Nikon
Eclipse Ti inverted microscope, with a Nikon 9 60 numer-
ical aperture [NA] 1.49 TIRF objective; Nikon UK, Ltd.,
Surrey, UK). Images were obtained at 5-s intervals for 20–
30 min at 37 °C, and this was followed by fixation in for-
malin and confocal imaging. Integrin a2b1 blockade was
achieved by preincubating platelets with 10 lg mL1 Gi9
blocking antibody. Platelet morphology was followed with
differential interference contrast (DIC) microscopy.
dSTORM
Alexa Fluor 647-204-11 Fab-labeled washed platelets
were allowed to adhere to collagenous substrate-coated
MatTek dishes. Adherent platelets were fixed, permeabi-
lized, and stained with phalloidin–Alexa Fluor 488. Sam-
ples were imaged in switching buffer as described
previously [22] on a Nikon Eclipse Ti-E N-STORM sys-
tem in dSTORM mode using Perfect Focus, with a CFl
SR Apochromat TIRF 9 100 oil, 1.49-NA objective lens
and an N-STORM filter cube with excitation from the
Agilent Ultra High Power Dual Output Laser bed (170-
mW, 647-nm laser), and image capture with an Andor
IXON Ultra 897 EMCCD camera. Thirty thousand
frames were captured with Nikon NIS ELEMENTS v4.2, and
reconstructed by the use of STORM ANALYSIS module v3.2,
with drift correction and Gaussian rendering of data
points. Detected points with a photon count of < 500
were discarded from reconstructed data before further
processing. Points in the reconstructed images represent
individually identified fluorescent blinking events, which
are referred to as molecules.
Confocal imaging
Platelets were preincubated with Alexa Fluor 488-conju-
gated or Alexa Fluor 647-conjugated 204-11 Fab
(4 lg mL1) alone or with another fluorescently labeled
antibody. In some experiments, platelets were also treated
with an inhibitor or inhibitory antibody. The platelets
were allowed to adhere to a collagenous substrate, fixed,
and imaged with an FV300 IX81 laser-scanning confocal
microscope with a 9 60 oil immersion objective (Olympus
UK, Southend-on-Sea, UK). Where indicated, platelets
were permeabilized (0.1% Triton/PBS) following fixation,
and stained for actin (Alexa Fluor 647–phalloidin) or
phosphotyrosine (4G10, 5 lg mL1).
Flow cytometry to measure GPVI dimer formation
Washed platelets were preincubated with dimethylsulfox-
ide (DMSO) (0.25% final concentration) or actin antago-
nist (cytochalasin D, latrunculin A, or jasplakinolide;
10 lM; 0.25% DMSO, final concentration), and GPVI
dimer formation was measured by flow cytometry [10].
Data analyses
Data analyses, performed with PRISM v7 (GraphPad, San
Diego, CA, USA), are described in the figure legends.
Differences among treatment groups in the flow cytome-
try experiments were calculated with paired t-tests.
dSTORM cluster analysis was performed within MATLAB
for each 3 9 3-lm region of interest (ROI), as described
by Owen et al. [23], with modifications described in Pollitt
et al. [18]. Platelets were identified by phalloidin staining
of the actin cytoskeleton. ROIs were positioned within
the platelet, ensuring that the edges of the ROI fell within
the platelet boundary. Clusters of < 3 points were dis-
counted. The numerical data, processed with Microsoft
Excel, were analyzed as detailed in the figure legends. The
degree of colocalization between the GPVI and phophoty-
rosine confocal images was quantified with IMAGE-PRO
PREMIERE 9.2 (Media Cybernetics, Rockville, MD, USA).
Results
TIRFM imaging of GPVI dimer cluster formation in live
platelets interacting with immobilized collagenous
substrates
We investigated the spatial and temporal distribution of
GPVI dimers on the surfaces of platelets interacting with
different immobilized collagenous substrates (Table 1).
Washed platelets labeled for GPVI dimer were allowed
to adhere, and cluster formation and dynamics were
visualized with TIRFM (Fig. 1; Movie S1). Discrete
clustered GPVI dimers can be visualized in spreading
platelets, whereas non-clustered GPVI dimers are poorly
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resolved, appearing as diffuse fluorescence over the pla-
telet surface.
GPVI dimers formed clusters on platelets adhered to
all collagenous substrates tested. Cluster formation on
fibrous Horm followed a distinct distribution, being con-
centrated along the collagen fiber (Fig. 1Ai,ii), initially
forming at the point of contact between the platelet and
the fiber, and then propagating along the fiber (Fig. 1Aii).
Clusters were not restricted to the visible collagen fiber,
but were also present on the platelet surface, presumably
because of indirect signal-induced clustering (e.g. outside-
in signaling through released substances such as fibrino-
gen, ADP, and VWF), through contact with smaller
(non-visible) fibers in these portions of the surface, or
both. The non-fibrous collagenous substrates CRP-XL
(Fig. 1B), Col III (Fig. 1C) and III-30 (Fig. 1D) also sup-
ported the formation of GPVI dimer clusters, each with
similar cluster distributions. Small clusters were evident
upon first contact of the platelet with the coated surface,
eventually forming throughout the platelet surface; some
clusters expanded and coalesced.
Different collagenous substrates induce different degrees of
clustering
GPVI clustering in fixed platelets spread on the different
collagenous substrates was quantified with dSTORM,
which has a typical x–y resolution of 20–30 nm [24,25].
Widefield TIRFM imaging of the platelets labeled for
F-actin and GPVI dimer showed the same distribution of
GPVI as that observed in the live-cell imaging (Fig. 2A).
Cluster analysis of dSTORM data is represented by the
heat maps in Fig. 2A. High and low levels of GPVI
clustering are shown as red and blue, respectively. All col-
lagenous substrates induced more GPVI clustering than
would be expected to occur randomly; however, the clus-
ter distribution depended on the specific substrate. Horm
induced high degrees of clustering along the fibers,
whereas the other substrates induced clusters that were
more evenly distributed throughout the ROI. Quantifica-
tion showed that there were more GPVI dimers and a
higher number of clusters per unit area on platelets
spread on Col III than on the other substrates (Fig. 2B,
C). These clusters were small (Fig. 2D), but contained the
highest density of GPVI dimers (Fig. 2E, median values).
Horm induced the next highest number of GPVI dimers
per ROI (42% less than Col III), and Horm-induced clus-
ters were 31% less dense than those on Col III. CRP-XL
and III-30 were least effective in inducing dimer forma-
tion (each with ~ 70% fewer molecules detected in the
ROI than with Col III), and cluster densities were also
correspondingly reduced as compared with Col III (40%
and 37% reduction, respectively). The GPVI dimer clus-
ters formed on Horm and CRP-XL were not significantly
different from each other in size, but were significantly
larger than those formed on Col III and III-30 (Fig. 2D).
In summary, all collagenous substrates caused GPVI
dimers to cluster, but different numbers of dimers and
Table 1 Collagenous substrates used in this study
Collagenous substrate Abbreviation Description Structure* Collagen receptor specificity
Cross-linked
collagen-related peptide†
CRP-XL Triple-helical,
crosslinked
GCO-(GPO)10GCOG-NH2 GPVI
Collagen Toolkit III peptide 30‡ III-30 Triple-helical GPC-(GPP)5-GAOGARGGA-
GPOGPEGGKGAAGPOGPO-
(GPP)5-GPC-NH2
GPVI
Horm collagen (equine, type I)§ Horm Fibrous
Type I
[a1(I)]2a2(I) GPVI
Integrin a2b1
Bovine collagen type I¶ Col I Non-fibrous [a1(I)]2a2(I) GPVI
Integrin a2b1
Bovine collagen type III¶ Col III Non-fibrous [a1(III)]3 GPVI
Integrin a2b1
*GPVI-binding GPO triplets are shown in bold type for CRP and III-30.
†CRP-XL was synthesized as described by Morton et al. [29].
‡Triple-helical peptide III-30 is from Collagen Toolkit III, a set of overlapping triple-helical peptides encompassing the entire collagen domain
of human collagen III; it was synthesized as described by Raynal et al. [30].
§Nycomed Pharma (1 mg mL1; Munich, Germany).
¶Koken (3 mg mL1; Tokyo, Japan).
Fig. 1. Glycoprotein VI forms clusters when platelets spread on immobilized collagenous substrates. Total internal reflection fluorescence
microscopy time courses of washed human platelets, labeled with Alexa Fluor 488-conjugated, dimer-specific 204-11 Fab, interacting with
10 lg mL1 immobilized collagenous substrates at 37 °C, are shown. (Ai) Horm collagen. (B) Cross-linked collagen-related peptide (CRP-XL).
(C) Non-fibrous collagen type III. (D) Peptide III-30. The positions of Horm collagen fibers are indicated on a differential interference contrast
image by the dashed lines (Aii). Images are of a single platelet representative of three independent experiments. See Movie S1. Time stamp: sec-
onds. Scale bar: 2 lm. [Color figure can be viewed at wileyonlinelibrary.com]
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Fig. 2. Direct stochastic optical reconstruction microscopy (dSTORM) analysis of glycoprotein VI (GPVI) clustering on collagenous substrates.
(A) Platelets spread on the collagenous substrates indicated were labeled for dimeric GPVI with the Alexa Fluor 647-conjugated Fab 204-11
(magenta) and F-actin by use of Alexa Fluor-488–phalloidin (green), and imaged by total internal reflection fluorescence microscopy (TIRFM)
(top row). GPVI was also imaged by dSTORM with the localized points (molecules) shown in the second row. The cluster heat map of the
GPVI dSTORM data in the 3 9 3-lm region of interest (ROI; dashed box in images) is shown in the third row, where red indicates high
degrees of clustering. The threshold value of a cluster was set to L(r) = 100. (B–E) Quantitative analysis of GPVI dSTORM clustering shows
the number of molecules detected in the 3 9 3-lm ROI (B), the number of clusters in the ROI (C), the size of the clusters (in nm2) (D), and
the density of the molecules within the clusters (E). All graphs have the median and interquartile range indicated in red. Statistical analysis:
non-parametric Kruskal–Wallis ANOVA with Dunn’s multiple comparison. Green lines indicate P < 0.001, the blue line indicates P < 0.01, and
the orange line indicates P < 0.05; no line indicates no significance. Scale bar: 5 lm. A total number of ≥ 70 ROIs taken from three or four
independent experiments were analyzed for each collagenous substrate. Col III, collagen III; CRP-XL, cross-linked collagen-related peptide;
Horm, Horm collagen.
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densities of GPVI within clusters were formed, depending
on the nature of the collagenous substrate.
GPVI dimers were not restricted to the platelet mem-
brane in direct contact with the visible collagen fibers
(Figs 1A and 2A). Potential explanations for this are the
existence of ‘non-visible’ microfibers in those areas, to
which GPVI dimers can still bind, and/or the fact that fib-
rinogen or other substances released from adherent plate-
lets may induce cluster formation via outside-in signaling.
To determine whether GPVI clusters can form by collagen-
independent platelet activation, platelets were spread on
fibrinogen, and clustering of GPVI dimers was quantified
with dSTORM (Fig. 3). GPVI dimer clusters seen on fib-
rinogen differed from those seen on Horm: the density of
dimers in platelets spread on fibrinogen was ~ 50% less
than that of dimers in platelets spread on Horm (Fig. 3B);
there were many more small clusters on the fibrinogen, and
the small clusters were ~ 40% less dense than those formed
on Horm (Fig. 3C–E). Although it is possible that GPVI
dimer clustering can occur by a GPVI-independent mecha-
nism, collagen greatly increases the formation of GPVI
dimers, which coalesce into larger and denser clusters.
Relationship between clustered GPVI dimers and other
receptors involved in the platelet–collagen interaction
The localizations of other receptors involved in the
platelet–collagen interaction, i.e. GPIb (Fig. 4A) and
integrin a2b1 (Fig. 4B), were compared with that of GPVI
dimer clusters on platelets adhered to collagenous
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Fig. 3. Comparison of glycoprotein VI (GPVI) clustering on Horm collagen (Horm) and fibrinogen. (A) Platelets spread on the Horm or fib-
rinogen as indicated at the top were labeled for dimeric GPVI with the Alexa Fluor 647-conjugated Fab 204-11 (magenta) and F-actin by the
use of Alexa Fluor 488–phalloidin (green), and imaged by total internal reflection fluorescence microscopy (TIRFM). GPVI was also imaged
by direct stochastic optical reconstruction microscopy (dSTORM) with the localized points (molecules) shown in the second row. The cluster
heat map of the GPVI dSTORM data in the 3 9 3-lm region of interest (ROI) (dashed box in images) is shown in the third row, where red
indicates high degrees of clustering. The threshold value of a cluster was set to L(r) = 100. (B–E) Quantitative analysis of GPVI dSTORM clus-
tering shows the number of molecules detected in the 3 9 3-lm ROI (B), the number of clusters in the ROI (C), the size of the clusters (in
nm2) (D), and the density of the molecules within the clusters (E). All graphs have the median and interquartile range indicated in red. Statisti-
cal analysis: if data passed a normality test, then a t-test was performed (for ‘number of clusters’). If data were not normally distributed, a
non-parametric Mann–Whitney test was used. ***P < 0.001. Scale bar: 5 lm. A total number of ≥ 90 ROIs taken from three independent
experiments were analyzed for each substrate. [Color figure can be viewed at wileyonlinelibrary.com]
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substrates. GPVI dimer clusters formed along Horm fibers,
whereas they appeared throughout the lamellipodia of pla-
telets spread on Col III and III-30. Like GPVI dimer clus-
ters, a2b1 was found to localize along Horm fibers, but was
confined to the cell bodies of platelets adhering to Col III
and III-30; no colocalization with GPVI dimer clusters
was observed on the platelet lamellipodia. GPIb (VWF
receptor) did not associate with GPVI dimer clusters in the
lamellipodia of any of the collagenous substrates tested,
remaining in the platelet cell body.
Contribution of collagen receptor a2b1 to platelet adhesion
and GPVI dimer cluster formation
Platelets labeled with Alexa Fluor 488-conjugated 204-11
Fab with or without Gi9 (a2b1-blocking antibody), were
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Fig. 4. Comparison of distributions of glycoprotein VI (GPVI) dimer clusters, glycoprotein Ib (GPIb) and integrin a2b1 on adhered platelets, and
the effect of inhibiting a2b1 on cluster formation and adhesion. (A, B) GPIb (set of 15 images in panel A) and a2b1 (set of 15 images in panel B):
confocal images of adhered platelets prelabeled with Alexa Fluor 488-conjugated 204-11 Fab (anti-GPVI-dimer; 4 lg mL1, green) and
Alexa Fluor 647-conjugated anti-human CD42 clone 486805 (anti-GPIb, 5 lg mL1, red) or Alexa Fluor 647-conjugated 16B4 (anti-a2b1;
5 lg mL1, red) and then allowed to adhere on collagen III (Col III)-coated, III-30-coated or Horm collagen (Horm)-coated dishes. Transmitted
light images are included to show the degree of spreading, and magnified images of the platelet(s), indicated by white arrows, are included. The dis-
tributions of GPIb were different from those of the GPVI dimers for all three collagenous substrates, and were not associated with the Horm fibers.
Integrin a2b1 bound to the Horm fibers, following a similar pattern as the GPVI dimer clusters, coinciding with GPVI dimer clusters at some
points, but not being associated with the lammelipodia of the platelets spread on Col III or III-30. (C, set of 8 gray scale images, right-side of the
figure) Total internal reflection fluorescence microscopy (TIRFM) images (15-min time point, upper row in each four-image group) and differential
interference contrast (DIC) images (lower row in each four-image group). Platelets were prelabeled with Alexa Fluor 488-conjugated 204-11 Fab,
treated with Gi9 (anti-a2b1, 5 lg mL
1; + Gi9) or an equal volume of phosphate-buffered saline (PBS) (No Gi9), and allowed to adhere on Col III
or Horm under TIRFMmonitoring for 30 min. Gi9 treatment decreased but did not prevent adhesion and GPVI dimer clustering on fibrous
Horm, but little or no adhesion was seen on Col III, even at the 30-min time point.
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allowed to settle onto immobilized non-fibrous Col III or
Horm fibers, and monitored with TIRFM. Gi9 treatment
prevented platelet adhesion to Col III, but merely
decreased the extent of GPVI dimer cluster formation on
Horm fibers (Fig. 4C). Gi9 had no effect on platelet
adhesion/cluster formation on the GPVI-specific ligands
CRP-XL and III-30 (data not shown).
Effect of Src-family and Syk kinase inhibition on GPVI
cluster formation
Confocal images of platelets adhered to Horm, Col III,
III-30 or CRP-XL showed that areas rich in phosphoty-
rosine colocalized with some of the GPVI dimer clusters
(Fig. 5A), suggesting that signaling was occurring in these
regions. The degree of colocalization was analyzed with
Pearson’s correlation (Fig. 5B, right). To investigate
whether protein tyrosine phosphorylation is important in
GPVI cluster formation, platelets were treated with the
Syk inhibitor PRT-060318 [2-((1R,2S)-2-aminocyclohexy-
lamino)-4-(m-tolylamino)pyrimidine-5-carboxamide] or the
Src-family kinase inhibitor PP2. Both inhibitors, at concen-
trations that have been demonstrated to inhibit spreading
and phosphorylation in human platelets [26], inhibited
adhesion on Horm and Col III. Both inhibitors reduced
platelet spreading on all collagenous substrates (Fig. S1
shows corresponding DIC images that enable visualization
of platelet morphology in the presence and absence of the
inhibitors). Despite having a reduction in spreading, dis-
crete GPVI dimer clusters were visible in platelets adhered
to CRP-XL and III-30 in the presence of PRT-060318 or
PP2 (Fig. 6).
Effect of disrupting actin dynamics on GPVI dimerization
and clustering
Flow cytometry was used to quantify the effects of drugs
that inhibit actin dynamics on GPVI clustering: cytocha-
lasin D and latrunculin A, which are actin polymerization
blockers, and jasplakinolide, which is an F-actin stabilizer.
All three inhibitors (10 lM) significantly decreased GPVI
dimer levels in resting platelets (Fig. 7A,B). To avoid total
abolition of adhesion, we used low-dose (2 lM) actin
antagonist to assess the role of the actin cytoskeleton in
clustering of GPVI dimers on Horm, Col III, CRP-XL,
and III-30 (Figs 7C–D). Low-dose latrunculin A disrupted
the actin cytoskeleton and severely depressed cluster for-
mation, with platelets that did adhere not spreading. Low-
dose jasplakinolide had similar but more severe effects on
cluster formation, with no apparent F-actin staining, and
fewer adhered but non-spread platelets.
Discussion
GPVI dimers constitutively present on resting platelets
represent the collagen-binding form of this receptor,
having over 100-fold higher affinity for collagen than the
monomer [9,10]. The constitutive presence of dimers sug-
gests that a mechanism beyond the formation of dimers
may be necessary to initiate signaling through GPVI. One
mechanism may be the formation of higher-order oligo-
mers (clusters), which has been demonstrated to play an
important role in the amplification, maintenance and ter-
mination of receptor signaling in many cell types [27,28],
including platelets [18,27]. We propose that GPVI clusters
may recruit signaling molecules to facilitate platelet acti-
vation. To explore this hypothesis, we used complemen-
tary imaging methods: TIRFM, dSTORM, and confocal
microscopy.
TIRFM enabled the temporal visualization of GPVI
cluster formation at the surfaces of platelets spreading on
collagenous substrates. After the initial contact of GPVI
dimer with the substrate, the number of GPVI dimer clus-
ters increased rapidly. Notably, in platelets adhered to
fibrous Horm, discrete clusters formed along the fibers
first, and then throughout the surface of the spread plate-
let (Fig. 1A). This is consistent with GPVI dimers interact-
ing with the surface of the collagen fiber, forming clusters
at those points, followed by signaling that induces more
cluster formation in regions of the platelet not in direct
contact with the visible fiber. A different clustering pattern
was observed on the immobilized non-fibrous collagenous
substrates CRP-XL (Fig. 1B) and III-30 (Fig. 1D), which
exclusively bind GPVI, and soluble Col III (Fig. 1C),
which binds GPVI and a2b1. Immobilized non-fibrous
substrates are randomly orientated triple-helical mole-
cules, and would be expected to support a different clus-
tering pattern than Horm fibers, which contain a highly
organized parallel assembly of triple-helical tropocollagen
molecules within the microfibrils. This structure dictates
that GPVI-binding sites will be distributed on the surface
of a fiber at fixed lateral and axial intervals, and suggests
that a GPVI dimer would be able to interact with neigh-
boring tropocollagen molecules presenting either separate
binding sites or a composite binding site [20].
dSTORM allows single fluorophore molecules to be
detected and located with very high spatial precision.
Combined with cluster analysis, dSTORM allows quan-
tification of the number of GPVI dimer molecules and
the cluster number, size and density in ROIs within a
spread platelet. This information permits the relative dif-
ferences in GPVI clusters to be compared in platelets
spread on different substrates. Horm fibers induced a
high degree of clustering by virtue of their structure, as
outlined above. The spacing and orientation of the two
proposed collagen-binding grooves of GPVI dimer might
allow it to bind with increased avidity to sites on adjacent
tropocollagen molecules, allowing clustering to occur [20].
The ability of immobilized III-30, CRP-XL and Col III
to bind GPVI will depend on the density and relative ori-
entation of the immobilized substrate helices. CRP-XL
and III-30 contain only GPVI-binding motifs, the former
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having more GPVI-reactive GPO triplets per molecule,
whereas immobilized soluble Col III binds both GPVI
and a2b1, which may support cooperative platelet bind-
ing, as motifs for the receptors are located close together.
Such differences may explain the variation in cluster
density observed between the different collagenous sub-
strates. Indeed, both Horm and Col III had significantly
higher GPVI cluster densities than III-30, and Col III
clusters were also significantly denser than those on CRP-
XL, suggesting a measurable role for a2b1 in these events.
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On platelets adhered to non-fibrous Col III and III-30,
GPIb (Fig. 4A) and a2b1 (Fig. 4B) did not colocalize with
the majority of the GPVI dimer clusters, which are
located in the lamellipodia of the spread platelet. How-
ever, a2b1 is indispensable for platelet binding to soluble
Col III, as adhesion was severely reduced by the blocking
anti-a2b1 antibody Gi9. Synergism between GPVI and
a2b1 has also been observed with immobilized model pep-
tides in flowing blood thrombus deposition studies [31].
In contrast, Gi9 did not prevent platelet adhesion/cluster
formation on fibrous Horm, indicating that GPVI binding
to the collagen fiber is much stronger than that to non-
fibrous substrates. These observations are consistent with
GPVI being sufficient to support platelet binding to colla-
gen fibers but not to soluble collagen [32]. Integrin a2b1
was also located along Horm fibers in bound platelets,
and the magnified confocal images (Fig. 4B) suggest that
a2b1 binds close to some of the GPVI dimer clusters on
the fiber. The model proposed by Herr and Farndale [20]
suggests that a2b1 and GPVI might bind ~ 10 nm apart
in Col III, and inspection of the collagen I sequence sug-
gests that similar considerations would apply to Horm.
Although non-activated a2b1 may bind its high-affinity
motif, GFOGER, in Horm fibers [33], this is not essential
for GPVI dimer binding and clustering. However, a2b1
may serve to accelerate platelet adhesion to the collagen
fiber [34], thus facilitating further GPVI clustering. Under
the present static adhesion conditions, however, the distri-
bution of GPIb differed from that of the GPVI dimer
clusters on collagen fibers, although GPIb was observed
in the platelet cell body, adjacent to the fiber (Fig. 4A). A
mAb against GPIb (SZ2) was reported to block CRP-
XL-induced platelet aggregation, and GPIb was reported
to coprecipitate with GPVI in both resting and thrombin-
stimulated platelets, suggesting an interaction between the
two receptors [35]. Platelet adhesion to collagen under
high shear requires VWF multimers, via GPIb, to tether
the platelet to collagen, but our experiments were per-
formed under static conditions in the absence of plasma
VWF, so GPIb was less important.
What induces GPVI clustering? One possibility is that
platelet activation induced by the initial interaction of
GPVI with collagen leads to GPVI oligomerization.
However, in spite of severe inhibition of platelet spread-
ing by the Syk inhibitor PRT-060318, limited cluster
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Fig. 6. Effect of signaling inhibitors on glycoprotein VI (GPVI)
dimer cluster formation in live platelets adhering to immobilized col-
lagenous substrate. Alexa Fluor 488-conjugated 204-11-labeled plate-
lets were reacted with dimethylsulfoxide (DMSO) (vehicle), 10 lM
PP2, or PRT-060318 (5 lM), and their adhesion to immobilized col-
lagenous substrate was then followed by total internal reflection fluo-
rescence microscopy. PRT markedly inhibited platelet adhesion to
all substrates, but the platelets that did adhere still showed GPVI
dimer cluster formation. The effect of PP2 was weaker but similar to
that of PRT. Col III, collagen III; CRP-XL, cross-linked collagen-
related peptide.
Fig. 5. Phospho-tyrosine (P-tyrosine) staining and glycoprotein VI (GPVI) dimer clustering. To determine whether signaling reactions may be
occurring in the vicinity of GPVI dimer clusters, washed platelets were prelabeled with Alexa Fluor 488-conjugated 204-11 Fab, and allowed to
adhere on collagenous substrate, and this was followed by formalin fixation, permeabilization with 0.5% Triton/phosphate-buffered saline, and
staining with 4G10 (anti-P-tyrosine)/Alexa Fluor 647-conjugated anti-mouse Fc. The experiments shown were performed with platelets of one
donor, on the same day, and with the same imaging conditions. (A) Confocal images show that, visually, P-tyrosine (red) was found among,
but not necessarily coincident with, the GPVI dimer clusters (green) for platelets adhered to collagen III (Col III), cross-linked collagen-related
peptide (CRP-XL), and III-30. Notably, the P-tyrosine staining in platelets adhered to Horm collagen (Horm) very closely followed the pattern
of GPVI dimer staining, which was mainly confined to the fibers. The morphology of spread platelets was identified by transmitted light. (B)
Calculation of colocalization. In the left set of figures, colocalized pixels are presented as a binary threshold mask, calculated with IMAGE PRO
PREMIER v9.2 (Media Cybernetics); they correspond to the respective merged images in (A). The graph on the right shows the calculated Pear-
son’s correlation coefficients for colocalization (mean  standard deviation), calculated from nine to 11 images, and they are as follows: Horm,
0.176  0.016; Col III, 0.106  0.046; CRP-XL, 0.216  0.024; and Toolkit peptide III-30, 0.079  0.057; the Pearson coefficients of the rep-
resentative images shown in (A) are 0.178, 0.166, 0.179 and 0.074 for Horm, Col III, CRP-XL and III-30, respectively. The Pearson’s coeffi-
cient for Horm was significantly different from those of Col III (***P < 0.001) and III-30 (***P < 0.001), but not different from that of CRP-
XL (paired t-test, PRISM v7). These values suggest that only some GPVI dimer clusters are localized with regions of high signaling activity; it is
notable that, under the limitations of the resolution afforded by the confocal microscope, both GPVI dimer clustering and signaling can be
seen along the Horm fibers. NS, not significant.
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formation on all four immobilized collagenous substrates
was still observed (Fig. 6, right). The marked inhibition
of cluster formation on Col III (which lacks the high-
affinity motif GFOGER) could be attributable to block-
ing of a2b1 activation, hence removing the contribution
of its high-affinity form to stabilizing platelet binding to
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collagen. The Src-family kinase inhibitor PP2 also inhib-
ited platelet adhesion, but to a lesser extent than PRT-
060318 (Fig. 6, middle). Alternatively, blockade of both
Src and Syk might potently inhibit secretion [36,37], pre-
venting the release of active substances (including fib-
rinogen), and thus reducing clustering via secondary
signaling pathways. These results suggest that, whereas
platelet adhesion and spreading is fully dependent on
GPVI-mediated signaling, GPVI cluster formation is
only partly so.
Movement of membrane proteins is controlled, in part,
by the cytoskeleton in other cells [38]. Inhibitors of actin
dynamics at 10 lM inhibited GPVI dimer formation in rest-
ing platelets, and prevented the GPVI dimer increase in
CRP-XL-activated or thrombin-activated platelets
(Fig. 7A,B). At 2 lM, a threshold inhibitory concentration,
there was severely limited adhesion of non-spread platelets
on all four tested substrates, but there was evidence of
residual cluster formation and disturbed actin filament dis-
tribution. These results suggest a contribution of the
peripheral membrane cytoskeleton to GPVI cluster forma-
tion, which is a topic for future investigation.
Although the GPVI dimers on resting platelets are
competent to bind collagen, they are not exposed to it in
an uninjured vessel, and the low density of GPVI dimers
in resting platelets (~ 1500 per platelet) [10] suggests that
they may be too far apart to induce efficient signaling;
thus, platelets remain inactive, the GPVI dimers requir-
ing both receptor ligation and proximity to activate pla-
telets. However, upon vessel injury, subendothelial
collagen fibers are exposed to the bloodstream, and effi-
cient platelet activation is necessary to prevent bleeding.
Once a vessel is injured, the binding sites on fibers of
collagen types I and III become accessible to the recep-
tors involved in the platelet–collagen interaction, i.e.
GPVI, a2b1, and GPIb. The proximity of GPVI dimer-
binding sites on the fiber surface enables clustering of
GPVI dimers, increasing avidity and bringing together
the necessary signaling components to initiate signaling
and lead to efficient platelet activation and thrombus
formation. We examined GPVI-dependent signaling in
the vicinity of GPVI clusters, and whether inhibitors of
GPVI-mediated signaling affected clustering. The proxim-
ity of phosphotyrosine to some of the GPVI clusters
(Fig. 5), particularly on the Horm fibers, suggests local
tyrosine kinase activity. Jamasbi et al. (39) recently
reported that GPVI-Fc (Revacept) bound to collagen
fibers can be clustered by the addition of anti-Fc, consis-
tent with dimers binding in close enough proximity in
the collagen fiber to allow cluster formation. Activation
induces the formation of more dimers, as shown by the
increased dimer numbers in CRP-XL-activated and
thrombin-activated platelets [10], enabling the formation
of even more clusters. Moreover, activation of platelets
leads to activation of a2b1, increasing its affinity for col-
lagen, causing firm adhesion. Our present study suggests
that platelets have two layers of activity regulation
through GPVI – conversion of monomers to high-affinity
dimers, and clustering of the GPVI dimers. Clustering
would serve to increase both avidity for collagen and
Fig. 7. Effect of actin antagonists on glycoprotein VI (GPVI) dimerization and GPVI dimer clustering. (A) Raw flow cytometry data: effects of
the actin antagonists latrunculin A (Lat A) and jasplakinolide (Jas) on the levels of dimers in resting and activated washed platelets were deter-
mined by flow cytometry (Accuri C6) with fluorescein isothiocyanate (FITC)-labeled mFab-F (dimer-specific). Also shown are a representative
histogram and dot-plots of the control (FITC-labeled anti-human Fab), non-treated resting platelets (no inhibitor, dimethylsulfoxide [DMSO]
vehicle at 0.2% final concentration), and Lat A (10 lM)-treated resting platelets (+ Lat A). There were no obvious differences in the platelet
region (SSC-A versus FL1-A plot) between the Lat-A-treated and non-treated resting platelets. However, the histogram (upper graph, FLA-1
versus count) shows that Lat A treatment markedly decreased the level of GPVI dimers, as shown by the clear leftward shift of the Lat A-trea-
ted platelets relative to the untreated resting platelets. (B) Comparison of effects of actin antagonists on GPVI dimer levels in resting and acti-
vated platelets. Washed platelets were treated with the vehicle (DMSO) or an actin antagonist at 10 lM: cytochalasin D (Cyt), Lat A, or Jas,
and then added with HEPES–Tyrodes buffer (resting), CRP-XL, or thrombin. The samples were processed for flow cytometry with FITC-
labeled mFab-F or FITC-labeled anti-human Fab (control). Differences among treatment groups were calculated with a paired t-test, by use of
PRISM v7. All tested actin inhibitors decreased GPVI dimer levels (mean fluorescence intensity, mean  standard error of the mean) in resting
platelets (Cyt, Lat A, and Jas, each P < 0.05, n = 5, as compared with the vehicle alone [0.2% DMSO, final concentration, n = 8]), in CRP-
XL-induced platelets (Cyt, Lat A, and Jas, each P < 0.05 [n = 5], as compared with 0.2% DMSO), and thrombin-induced platelets (Cyt and
Jas, each P < 0.05 [n = 5], and Lat A, P < 0.005 [n = 5], as compared with 0.2% DMSO). (C–F) Confocal images of GPVI dimers and F-actin
in non-treated and actin-antagonist-treated platelets adhered to Horm collagen (C), collagen III (D), CRP-XL (E), and III-30 (F). Washed pla-
telets labeled with Alexa Fluor 488-conjugated 204-11 Fab (green), with or without treatment with Lat A or Jas, were allowed to adhere on
immobilized collagenous substrate, formalin-fixed, permeabilized, and then stained for F-actin with Alexa Fluor 647–phalloidin. Lat A (2 lM)
and Jas (2 lM) were used at threshold inhibitory concentrations, so that platelet adhesion was not completely prevented. Images were obtained
on a confocal microscope, and the following images are shown: gray scale images of GPVI dimer and F-actin; merged images (green, GPVI
dimer clusters; and red, F-actin); and transmitted light images. Lat A severely inhibited the formation of large GPVI clusters, but a limited
number of small clusters could still be observed for platelet adhesion to all tested collagenous substrates. The spreading was clearly inhibited
on all of the collagenous substrates. Jas produced more severe inhibition of F-actin, and no F-actin staining could be observed in the Jas-trea-
ted platelets. In the Jas-treated platelets, some green fluorescence could still be observed in the adhered cells, but it is not clear whether this cor-
responded to small GPVI clusters or was attributable to the higher density of residual GPVI dimers resulting from the much more compact
size of the non-spread platelets. Note that, in spite of the cytoskeleton being severely compromised in the inhibitor-treated platelets and the
total inhibition of spreading, the platelets had residual ability to adhere to the collagenous substrates, possibly because of GPVI dimers, and
this was most evident in the platelets adhered along the Horm collagen fibers in the Lat A-treated or Jas-treated preparations. [Color figure
can be viewed at wileyonlinelibrary.com]
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signaling molecule recruitment, leading to efficient plate-
let activation during thrombus formation.
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Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Movie S1. GPVI forms clusters when platelets spread on
immobilized collagenous substrates.
Fig. S1. DIC images corresponding to the fluorescence
images in Fig. 6.
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